摘要
目的:研究按中医体质辨识理论拟定的龟芍方对格雷夫斯病(Graves病)伴肝损害甲状腺功能及肝功能的改善作用与机制。方法:选取Graves病伴肝损害患者50例,随机分成两组,治疗组25例给予龟芍方加甲巯咪唑片治疗,对照组25例采用复合磷酸酯酶肠溶片加甲巯咪唑片治疗,疗程均为12周。观察两组治疗前后游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素受体抗体(TRAb)、谷丙转氨酶(glutamic-pyruvic transaminase,ALT)、谷草转氨酶(AST)、总胆红素(TBIL)、白细胞介素-17A(IL-17A)、白细胞介素-17F(IL-17F)、白细胞介素-23(IL-23)的变化。结果:经12周治疗,两组患者各异常指标较前均有改善。其中治疗组显效7例,有效15例,无效3例,总有效率为88.0%;对照组中显效3例,有效13例,无效9例,总有效率64.0%;两组有效率比较,差异有统计学意义(P<0.05)。治疗组经12周治疗后各项指标均显著低于对照组,差异有统计学意义(P<0.05)。结论:龟芍方对Graves病伴肝损害患者的甲状腺功能及肝功能有改善作用,其机制与调节细胞免疫有关。
Objective:To study the effect and mechanism of Decoction of GuiShao according to the TCM constitution for improving thyroid function and liver function on Graves'disease with liver damage.Methods:50 patients were randomly divided into two groups.25 cases in the treatment group were treated with GuiShao Decoction and methimazole,others in the control group were treated with Phosphoesterase Complex Enteric-coated Tablets and methimazole,and the course for all was 12 weeks.Changes of free triiodothyronine(FT3),free thyroxine(FT4),thyrotropin receptor antibody(TRAb),glutamic-pyruvic transaminase(ALT),glutamic-oxalacetic transaminase(AST),total bilirubin(TBIL),interleukin-17 A(IL-17A),interleukin-17F(IL-17F),interleukin-23(IL-23)were observed before and after treatment.Results:All the above-mentioned indexes were improved after 12 weeks'treatment in both groups.In treatment group 7 cases were excellent,15 ones effective,and 3 ones ineffective.The total effective rate was 88.0%.In control group 3 cases were excellent,13 ones effective,and 9 ones ineffective.The total effective rate was 64.0%.There was significant differe nee between the two groups(P<0.05).After 12 weeks'treatment,all the above-mentioned indexes were significantly lower in treatment group than those in control group(P<0.05).Conclusion:Decoction of GuiShao has therapeutic effect on thyroid function and liver function,who suffers from Graves'disease with liver damage.Its possible mechanism is related with the regulation on cell immunity.
作者
徐春莉
唐琳
王玉
胡萍
徐筱玮
Xu Chunli;Tang Lin;Wang Yu;Hu Ping;Xu Xiaowei(The First Clinical College,Shandong University of Traditional Chinese Medicine,Jinan 250014,China;The Affiliated Hospital of Qingdao University,Qingdao 266000,China;Qingdao Hiser Medical Group,Qingdao 266033,China)
出处
《亚太传统医药》
2019年第3期162-165,共4页
Asia-Pacific Traditional Medicine
关键词
格雷夫斯病
甲亢性肝损害
自身免疫
中医体质
中医治疗
Graves' Disease
Hyperthyroidism Liver Damage
Autoimmunity
TCM Constitution
TCM Therapy